Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

BlackRock, Inc. reported a 12.20% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed Apr 24, 2026

BlackRock, Inc. reported a 12.20% stake in Arrowhead Pharmaceuticals, Inc., 17,104,084 shares, as a passive investor on Mar 31, 2026. Filed Apr 24, 2026 (Schedule 13G/A).

Stake
12.20%
Shares
17,104,084
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.12.20%17,104,084

Source

View original at SEC

Related